Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yalei Wen

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology in Drug Development|June 26, 2024
Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting StateShengling Hu, Yalei Wen, Jing Li, et al.
Experimental Cell Research|December 1, 2023
Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1Xiuqing Ma, Rui Wan, Yalei Wen, et al.
European Journal of Medicinal Chemistry|January 10, 2022
Efficient targeted oncogenic KRAS<sup>G12C</sup> degradation via first reversible-covalent PROTACFang Yang, Yalei Wen, Chaofan Wang, et al.
Cell Death Discovery|February 27, 2021
Transcriptional network constituted of CBP, Ku70, NOX2, and BAX prevents the cell death of necrosis, paraptosis, and apoptosis in human melanomaLiang Ding, Yalei Wen, Xin Zhang, et al.
Frontiers in Pharmacology|October 31, 2022
Chronic inflammation, cancer development and immunotherapyYalei Wen, Yingjie Zhu, Caishi Zhang, et al.
Molecules (Basel, Switzerland)|February 12, 2020
Design, Synthesis and Characterization of a Novel Type of Thermo-Responsible Phospholipid Microcapsule-Alginate Composite Hydrogel for Drug DeliveryLiang Ding, Xinxia Cui, Rui Jiang, et al.
Acta Pharmaceutica Sinica. B|April 4, 2024
High-throughput discovery of highly selective reversible hMAO-B inhibitors based on at-line nanofractionationYu Fan, Jincai Wang, Jingyi Jian, et al.
Nature Communications|January 20, 2026
Targeting the UFL1-AKT cascade suppresses triple-negative breast cancer progressionXiao Yang, Yalei Wen, Xiuqing Ma, et al.
Journal of the American Chemical Society|June 13, 2025
Covalent Recruitment of NEDD4 for Targeted Protein Degradation: Rational Design of Small Molecular DegradersXiaoqiang He, Shihan Zeng, Yalei Wen, et al.
Journal of Cellular Physiology|August 29, 2023
OTUD4 regulates metastasis and chemoresistance in melanoma by stabilizing Snail1Yuchen Gao, Jiaxin Tang, Xiuqing Ma, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology in Drug Development|June 26, 2024
Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting StateShengling Hu, Yalei Wen, Jing Li, et al.
Experimental Cell Research|December 1, 2023
Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1Xiuqing Ma, Rui Wan, Yalei Wen, et al.
European Journal of Medicinal Chemistry|January 10, 2022
Efficient targeted oncogenic KRAS<sup>G12C</sup> degradation via first reversible-covalent PROTACFang Yang, Yalei Wen, Chaofan Wang, et al.
Cell Death Discovery|February 27, 2021
Transcriptional network constituted of CBP, Ku70, NOX2, and BAX prevents the cell death of necrosis, paraptosis, and apoptosis in human melanomaLiang Ding, Yalei Wen, Xin Zhang, et al.
Frontiers in Pharmacology|October 31, 2022
Chronic inflammation, cancer development and immunotherapyYalei Wen, Yingjie Zhu, Caishi Zhang, et al.
Molecules (Basel, Switzerland)|February 12, 2020
Design, Synthesis and Characterization of a Novel Type of Thermo-Responsible Phospholipid Microcapsule-Alginate Composite Hydrogel for Drug DeliveryLiang Ding, Xinxia Cui, Rui Jiang, et al.
Acta Pharmaceutica Sinica. B|April 4, 2024
High-throughput discovery of highly selective reversible hMAO-B inhibitors based on at-line nanofractionationYu Fan, Jincai Wang, Jingyi Jian, et al.
Nature Communications|January 20, 2026
Targeting the UFL1-AKT cascade suppresses triple-negative breast cancer progressionXiao Yang, Yalei Wen, Xiuqing Ma, et al.
Journal of the American Chemical Society|June 13, 2025
Covalent Recruitment of NEDD4 for Targeted Protein Degradation: Rational Design of Small Molecular DegradersXiaoqiang He, Shihan Zeng, Yalei Wen, et al.
Journal of Cellular Physiology|August 29, 2023
OTUD4 regulates metastasis and chemoresistance in melanoma by stabilizing Snail1Yuchen Gao, Jiaxin Tang, Xiuqing Ma, et al.
Pageof 3